U.S., April 10 -- ClinicalTrials.gov registry received information related to the study (NCT07521358) titled 'Magnesium Supplementation With Fluoxetine for Cognitive Function in Depression' on April 03.
Brief Summary: The goal of this clinical trial is to evaluate whether magnesium supplementation can improve cognitive function in patients with depression receiving fluoxetine therapy. It also aims to assess its effect on serum brain-derived neurotrophic factor (BDNF) levels in adult patients with depression.
The main questions it aims to answer are:
* Does magnesium supplementation improve cognitive function in patients with depression receiving fluoxetine?
* Does magnesium supplementation increase serum BDNF levels in these patients? R...